LUNG FUNG GROUP

2290
3.8904.99% ( +0.185 )
Delay Closed: Nov 16, 16:08:11

Overview

LUNG FUNG GROUP (2290)

Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. The company offers Chinese and western medicines,...

Open
3.790
High
3.895
Low
3.700
Prev. Close
3.705
Volume
2.08M
Turnover
8.01M
Avg Price
3.843
Bid/Ask Ratio
-43.28%
Amplitude
5.26%
52wk High
4.700
Volume Ratio
0.69
Turnover Ratio
0.42%
52wk Low
2.010
HK Mkt Cap
1.95B
Market CapHKD
1.95B
P/ETTM
7.23
P/EDynamic
7.23
P/EStatic
--
EPSTTM
0.538
EPSDynamic
0.538
EPSStatic
--
BVPS
0.09
P/B
42.17
HK Shares
500.00M
Dividend YieldTTM
3,933.16%
DividendTTM
153
Shares
500.00M
Min lot size
500
Currency
HKD

LUNG FUNG GROUP Analyst Rating

View more

Forecast & Rating

Sep 30, 2026
Price forecast
HK$7.98105.14%
Forecast & RatingBuy
1analysts
  • Strong buy0.00%
  • Buy100.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Nov, 16

    Lung Fung Group Holdings rose about 5.0% to HK$3.890 from a prior close of HK$3.705, tracing a one-way advance from the 09:30 session low of HK$3.705 to an intraday peak of HK$3.895 at 15:53, as store expansion drove double-digit same-store sales growth and DBS projected 20% revenue growth for 1H FY2027 with a Buy rating. Q1 2026 revenue reached HK$697.4 million, up 42.48% year on year, net profit came in at HK$47.76 million, up 130.68%, and net margin widened to 6.85% from 4.23%, while the consensus target price was lifted 25.20% to HK$10.19. The stock is up 38.43% year to date, above its MA20 of HK$3.696 but still below MA60 of HK$3.993, and sits 17.23% below its 52-week high of HK$4.70, with PE at 7.23x and market value HK$1.945 billion. Volume remains thin, though, with the shares up only 2.07% earlier in the week and the turnover rate at 0.42%.

  2. Oct, 23

    Lung Fung Group opened weak but climbed, dipping to HK$3.63 in the morning session before spiking to HK$3.885 in the afternoon and closing at HK$3.740, up about 0.9% from the prior close of HK$3.705 on roughly 1.8 million shares. The move was underpinned by fundamentals and sell-side expectations: Q1 2026 revenue reached HK$697.4 million, up 42.5% year-on-year, with net profit of HK$47.76 million up 130.7% and net margin widening to 6.85% from 4.23%; interim in-store retail sales were about HK$1.7195 billion, up 18.9%, with same-store growth of 10.2%, while DBS expects first-half revenue growth of about 20% and the consensus price target was raised 25.2% to HK$10.19. Though the shares still trade below the MA20 of HK$4.274 and MA60 of HK$3.981, about 20.4% under the 52-week high of HK$4.70, and are up 33.1% year-to-date.

  3. Oct, 21

    Lung Fung Group (2290.HK) spiked and faded: it printed HK$4.055 at 09:39 BJ, slid to HK$3.730 by 10:33, then traded between HK$3.795 and HK$3.865 in the afternoon to close at HK$3.825, about 4.3% under the prior close of HK$3.995 on roughly HK$10.58m turnover. No matching new disclosure appeared, so the move reads more like profit-taking after the HK$4.70 52-week high of 8 October, leaving the shares 18.94% below that peak and under both the MA20 (HK$4.333) and MA60 (HK$3.976), while still up 35.59% year-to-date. Fundamentals point the other way: Q1 revenue of HK$697.4m and net profit of HK$47.8m rose 42.48% and 130.68% year-on-year, net margin widening from 4.23% to 6.85%, DBS expects roughly 20% H1 revenue growth and the consensus target was lifted 25.20% to HK$10.19. A counterpoint: the company also disclosed leasing new premises from chairman Tse Siu Hoi and renewing two leases.

  4. Oct, 16

    Lung Fung Group (2290.HK) reversed intraday, opening at 4.405 HKD as the session high before sliding to 4.055 HKD at 14:44 BJ and settling at 4.170 HKD, roughly 5% below the open, on 1.503 million shares and a 0.30% turnover rate. The tape contrasted with firmer operating data: half-year same-store sales grew 10.2% with in-store retail sales of about 1.7195 billion HKD, up roughly 18.9% year on year, while Q1 2026 revenue reached 697.4 million HKD (+42.48%), net profit 47.76 million HKD (+130.68%) and net margin widened to 6.85% from 4.23%. At a 2.085 billion HKD market capitalisation the shares trade on 7.75x earnings and remain below the 10.19 HKD consensus target, which was raised 25.20% this week; DBS expects first-half revenue growth of 20%, and the company has leased a ground-floor shop on Canton Road in Tsim Sha Tsui for 800,000 HKD a month, though thin volume limits price elasticity.

  5. Oct, 15

    Lung Fung Group Holdings reversed early gains, climbing to HK$4.495 in the morning before sliding to an intraday low of HK$4.265 in the afternoon session and closing at HK$4.270, down 5.3% from the previous close of HK$4.510. The pullback leaves the shares about 9.15% below the 52-week high of HK$4.70 set on 8 October, still up 51.96% year to date, while the close has slipped under the 20-day moving average of HK$4.384. Fundamentals run the other way: Q1 2026 revenue grew 42.48% year on year to HK$697.4 million and net profit rose 130.68% to HK$47.76 million. DBS expects first-half revenue growth of 20%, the consensus target was raised 25.20% from HK$8.14 to HK$10.19, and the company leased a ground-floor shop on Canton Road in Tsim Sha Tsui at HK$800,000 monthly rent. Turnover stays thin, though, at 0.26% with a 7.93x P/E.

News